Psych Capital Plc
Develops psilocybin-based therapies for anorexia nervosa and other mental health conditions.
PSY | IL
Overview
Corporate Details
- ISIN(s):
- GB00BL6CJQ54
- LEI:
- 213800WXCQ1C6GPLHH68
- Country:
- United Kingdom
- Address:
- 17 HANOVER SQUARE, W1S 1BN LONDON
- Website:
- https://psych.capital/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Shortwave Life Sciences Plc, formerly Psych Capital Plc, is a life sciences company focused on developing innovative treatments for mental health conditions. The company's lead clinical program is centered on a psilocybin-based therapy for anorexia nervosa, a life-threatening condition with no currently FDA-approved medication. Leveraging an IP-driven approach rooted in the Israeli innovation ecosystem, Shortwave utilizes a capital-efficient economic model that combines in-house capabilities with strategic partnerships for drug discovery and development. The firm is dedicated to identifying, operating, and creating value from early-stage, breakthrough initiatives to address unmet patient needs in eating disorders and mental healthcare.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Psych Capital Plc and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-10 08:00 |
Board/Management Information
Direction, Director Changes and Medical Adviser
|
English | 20.9 KB | |
| 2025-08-19 13:50 |
Major Shareholding Notification
Holding(s) in Company
|
English | 56.0 KB | |
| 2025-08-04 12:00 |
Board/Management Information
Clarification on Strategic Advisor Appointment
|
English | 6.0 KB | |
| 2025-07-29 08:00 |
Share Issue/Capital Change
£250k Fundraising, New Directors & Review
|
English | 27.3 KB | |
| 2025-06-24 14:10 |
Major Shareholding Notification
AQSE Only - Holding(s) in Company
|
English | 56.2 KB | |
| 2025-06-16 11:21 |
Major Shareholding Notification
Holding(s) in Company
|
English | 56.2 KB | |
| 2025-01-31 17:52 |
Earnings Release
Interim Results to 31 October 2024
|
English | 115.6 KB | |
| 2024-12-23 13:00 |
Share Issue/Capital Change
Pre-Crowdfunding re Groundbreaking Treatment
|
English | 9.5 KB | |
| 2024-11-29 16:16 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 7.2 KB | |
| 2024-11-27 15:12 |
Board/Management Information
Director Appointment and SPA Update
|
English | 26.7 KB | |
| 2024-10-31 18:39 |
Annual Report
YEAR ENDED 30 APRIL 2024 AND DIRECTOR RESIGNATION
|
English | 176.8 KB | |
| 2024-09-19 08:00 |
Regulatory News Service
Positive Pre-Clinical Result Drive to Human Trials
|
English | 10.7 KB | |
| 2024-07-31 13:05 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 7.2 KB | |
| 2024-07-17 18:20 |
Major Shareholding Notification
TR1: Notification of Major Holdings
|
English | 75.8 KB | |
| 2024-07-08 08:00 |
Share Issue/Capital Change
Company’s Patent Claims Confirmed
|
English | 31.5 KB |
Automate Your Workflow. Get a real-time feed of all Psych Capital Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Psych Capital Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
